This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by From, A H Articles by Good, R A Search for Related Content PubMed PubMed Citation Articles by From, A H Articles by Good, R A

 Previous Article  |  Next Article 

Infect Immun. 1979 March; 23(3): 660-664

Polymyxin B sulfate modification of bacterial endotoxin: effects on the development of endotoxin shock in dogs.

ABSTRACT

The effects of endotoxin (lipopolysaccharide [LPS]) on the pathogenesis of canine endotoxin shock were compared with those of LPS which had interacted with polymyxin B sulfate prior to administration. Both LPS and polymyxin B-modified LPS caused comparable early decreases in aortic blood pressure, leukocyte and platelet numbers, and serum complement levels. However, in dogs receiving polymyxin B-modified LPS the late hypotensive phase was significantly ameliorated and lethality was significantly decreased. These data indicate that polymyxin B-modified LPS, though significantly less lethal than unmodified LPS, was capable of major interactions with several components of the humoral defense system, and support the concept that such interactions are not determinative in the pathogenesis of canine endotoxin shock.

This article has been cited by other articles:

• Fuchs, P. C., Barry, A. L., Brown, S. D. (1998). PMX-622 (Polymyxin B-Dextran 70) Does Not Alter In Vitro Activities of 11 Antimicrobial Agents. Antimicrob. Agents Chemother. 42: 2765-2767 [Abstract] [Full Text]